Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2010 / Cilt: 44 - Sayı: 1

The prevalance of diabetes in psoriatic patients versus the prevalance of psoriasis in diabetic patients

Psoriasisli hastalarda diyabet görülme sıklığına karşılık diyabetli hastalarda psoriasis görülme sıklığı

Pages
12–14
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The age and sex-adjusted proportion of diabetes was significantly higher in psoriatic patients as compared the proportion of psoriasis in diabetic patients (OR: 18.35, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Previous studies reported that there are some relations between psoriasis and the diabetes mellitus.
📊
Key Findings & Data:However, incidence rates of diabetes mellitus in psoriasis and also incidence rates of psoriasis in diabetes mellitus are lacking.
💡
Conclusion & Impact:The age and sex-adjusted proportion of diabetes was significantly higher in psoriatic patients as compared the proportion of psoriasis in diabetic patients (OR: 18.35, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: Previous studies reported that there are some relations between psoriasis and the diabetes mellitus. However, incidence rates of diabetes mellitus in psoriasis and also incidence rates of psoriasis in diabetes mellitus are lacking. Our aim was to assess and compare incidence rates of diabetes mellitus in patients with psoriasis and incidence rates of psorasis in diabetes mellitus and also evaluate the role of psoriasis as a risk factor for diabetes mellitus. Material and Method: Four hundred eighteen patients with psoriasis and one hundred fifty four patients with diabetes were included. Blood glucose, oral glucose tolerance test (OGTT), glycolised hemoglobine (HbA1C) were performed in psoriatic patients and these results were consulted with diabetes clinic. Psoriasis screening by clinical history, dermatologic examination, skin biopsy; if it is necessary were held for patients with diabetes. Results: Prevalance of diabetes was 9.3% in psoriatic patients; prevalance of psoriasis was 1.3% in diabetic patients. The proportion of diabetes was significantly higher in psoriatic patients compared to the proportion of psoriasis in diabetic patients (odds ratio (OR): 7.82, confidence interval (CI): 1.86-32.79, p=0.001). The age and sex-adjusted proportion of diabetes was significantly higher in psoriatic patients as compared the proportion of psoriasis in diabetic patients (OR: 18.35, p

Özet

Amaç: Psoriasis ile diyabet birlikteliği öteden beri kabul edilmesine karşın salt psoriasis diyabet ilişkisini araştıran çok az sayıda çalışma bulunmaktadır.Amacımız psoriasisli hastalarda diyabetes mellitus, diyabetes mellituslu hastalarda psorasis sıklığını değerlendirmek ve karşılaştırmak; aynı zamanda psorasisin diyabetes mellitusa predispozisyon yaratıp yaratmadığını araştırmaktı. Gereç ve Yöntem: Dört yüz on sekiz psoriasis hastası ile yüz elli dört diyabet hastası çalışmaya alındı. Hastalar çalışma hakkında bilgilendirilip onam formları imzalatıldı. Psoriasisli hastalarda açlık kan şekeri (AKŞ), glikolize hemoglobin (HbA1C) ve oral glukoz tolerans testi (OGTT) ölçümleri yapıldı ve diyabet polikliniği ile konsülte edildi. Diyabet hastalarında ise öykü, dermatolojik muayene ve gerekli durumda deri biyopsisi ile psoriasis taraması yapıldı. Bulgular: Psoriasisli hastalarda %9,3 oranında diyabete rastlanmasına karşılık diyabeti olanlarda %1,3 oranında psoriasis görüldü. Psoriasisli hastalarda diyabet görülme sıklığı, diyabetli hastalarda psoriasis görülme sıklığına göre anlamlı olarak yüksek bulundu (OR: 7,82, Cl: 1,86-32,79, p=0,001). Hasta grupları arasında yaş ve cinsiyet farklılıkları düzeltildikten sonra psoriasisli hastalarda diyabet görülme oranı, diyabetli hastalarda psoriasis görülme oranına göre anlamlı olarak yüksek saptandı (OR: 18,35, p0,05). Sonuç: Sonuçlarımız psoriasisli hastalarda diyabet riskinin arttığını gösterdi. Kronik inflamasyon insülin ilişkisinin tip 2 diyabet gelişimine zemin hazırladığı düşünülebilir.Ancak hastaların kullandığı tedavilerin özellikle potent steroidlerin tabloyu etkileyip etkilemediği konusunda yorum yapmak oldukça zor görünmektedir. Sebep ne olursa olsun psoriasisli hastalar tip 2 diyabet ve diğer metabolik bozukluklar yönünden yakından izlenmelidir.

🔖

Cite This Article

SU, Ö., ŞENOCAK, M., DAVUTOĞLU, M., CEBECİ, F., ERİŞ, Z., ONSUN, N. (2022). The prevalance of diabetes in psoriatic patients versus the prevalance of psoriasis in diabetic patients. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 44 - Sayı: 1, 12–14. https://ajindex.com/articles/622010

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Gudjonsson JE, Elder JT: Psoriasis: epidemiology. Clin Dermatol 2007;25:535-46
  2. Langley RG, Krueger GG, Griffiths CE: Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005;64:18-23
  3. Naldi L: Epidemiology of psoriasis. Curr Drug Targets in Inflamm Allergy 2004;3:121-8
  4. Cristophers E. Comorbidities in psoriasis. Clin Dermatol 2007; 25:529-34
  5. Gurel MA, Adısen A. Psoriasis, Genel bilgiler, Epidemiyoloji. Türkderm 2008;42 (Özel sayı) 2:15-7
  6. Gisondi P, Tesari G, Centi A et al: Prevalance of metabolic syndrome in patients with psoriasis a hospital-based case-control study. Br J Dermatol 2007;157:68-73
  7. Brauchli YB., Jick SS, Meier CR: Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol 2008; 159:1331-7
  8. Sommer DM, Jenisch S, Suchan M et al: Increased prevalance of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006;298:321-8
  9. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM: Prevalance of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006;55:829-35
  10. Sterry W, Strober BE, Menter A: Obesity in psoriasis; the metabolic, clinical and therapeutic implications. Report of an interdiciplinery conference and review. Br J Dermatol 2007;157:649-55
  11. Shapiro J, Cohen AD,David M et al.The association between psoriasis, diabetes mellitus and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007;56:629-34
  12. Boehncke S, Thaci D, Beschmann H et al: Psoriasis patients show signs of insulin resistance. Br J Dermatol 2207;159:1249-51
  13. Gülekon A, Adışen E: Psoriasis ve komorbiditeler. Turkderm 2008; 2 (özel sayı):23-5
  14. Choi, Koo JY: Quality of life issues in psoriasis. J Am Acad Dermatol 2003;49:57-61
  15. Mukhtar R, Choi J, Koo JY: Quality-of-life issues in psoriasis. Dermatol Clin 2004;22:389-95
  16. Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S: An ‹talian study on psoriasis and depression. Dermatology 2006; 212:123-7
  17. Gupta MA, Gupta AK: Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003;4:833-42
  18. Patja K, Jousilahti P, Hu G, Vale T, Qiav Q, Tuomilehto J: Effects of smoking, obesity and physical activity on the risk of type 2 diabetes in middle-aged. Finnish men and women J Intern Med 2005;258:356-62
  19. Cohen AD, Dreiter J, Shapiro J et al: Psoriasis and